Detection of a 4-bp Insertion/deletion Polymorphism within the Promoter of EGLN2 Using Mismatch PCR-RFLP and Its Association with Susceptibility to Breast Cancer

It has been shown that a 4-bp insertion/deletion (ins/del) polymorphism of EGLN2 influences the risk of several cancers. However, to date, no study has inspected the impact of the 4-bp ins/del polymorphism on breast cancer (BC) risk. A case-control study, including 134 breast cancer patients and 154...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Asian Pac J Cancer Prev
Hlavní autoři: Hashemi, Mohammad, Danesh, Hiva, Bizhani, Fatemeh, Sattarifard, Hedieh, Hashemi, Seyed Mehdi, Bahari, Gholamreza
Médium: Artigo
Jazyk:Inglês
Vydáno: West Asia Organization for Cancer Prevention 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6031807/
https://ncbi.nlm.nih.gov/pubmed/29693343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2018.19.4.923
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky